deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT01638416

Standard Issue Transfusion Versus Fresher Red Blood Cell Use in Intensive Care- A Randomised Controlled Trial (TRANSFUSE)

A Multi-centre Randomised Double Blinded Phase III Trial of the Effect of Standard Issue Red Blood Cell Blood Units on Mortality Compared to Freshest Available Red Blood Cell Units

Sponsor: Australian Red Cross

Interventions Blood transfusion
Updated 12 times since 2017 Last updated: Oct 19, 2020 Started: Oct 31, 2012 Primary completion: Apr 30, 2017 Completion: Jun 30, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01638416, this PHASE3 trial focuses on Age of Blood and Transfusion and remains completed. Sponsored by Australian Red Cross, it has been updated 12 times since 2012, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~Sep 2017 · 7 months · monthly snapshotActive Not Recruiting~Sep 2017 – ~Jun 2018 · 9 months · monthly snapshotCompleted~Jun 2018 – ~Nov 2020 · 29 months · monthly snapshotCompleted~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotCompleted~Dec 2021 – ~Dec 2022 · 12 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Feb 2023 · 31 days · monthly snapshotCompleted~Feb 2023 – ~Jul 2024 · 17 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

12 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Feb 2023 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jan 2023 — Feb 2023 [monthly]

    Completed PHASE3

  5. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE3

Show 7 earlier versions
  1. Dec 2021 — Dec 2022 [monthly]

    Completed PHASE3

  2. Jan 2021 — Dec 2021 [monthly]

    Completed PHASE3

  3. Nov 2020 — Jan 2021 [monthly]

    Completed PHASE3

  4. Jun 2018 — Nov 2020 [monthly]

    Completed PHASE3

  5. Sep 2017 — Jun 2018 [monthly]

    Completed PHASE3

    Status: Active Not RecruitingCompleted

  6. Feb 2017 — Sep 2017 [monthly]

    Active Not Recruiting PHASE3

    Status: RecruitingActive Not Recruiting

  7. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE3

    First recorded

Oct 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Australian Red Cross
  • Australian and New Zealand Intensive Care Research Centre
  • Finnish Red Cross Blood Service
  • Irish Blood Transfusion Service
  • King Abdulaziz Medical City
  • New Zealand Blood Service
  • University College Dublin
Data source: Australian and New Zealand Intensive Care Research Centre

For direct contact, visit the study record on ClinicalTrials.gov .